|
|
|
|
Insulin study could lead to new dosage devices
Buy Maxalt Without a Prescription Buy no Prescription Strattera Order Tamiflu no Prescription Online Buy Medrol Without a Prescription Buy Naltrexone Without a Prescription Buy no Prescription Antabuse Online Buy Boniva no Prescription Buy Propecia Without a...
|
|
|
AstraZeneca faces as many as 26,000 Seroquel lawsuits
As many as 26,000 lawsuits have been filed against AstraZeneca claiming that its antipsychotic Seroquel causes diabetes, court documents show.In a regulatory filing, AstraZeneca officials said the company's spending on Seroquel cases has...
|
|
|
AstraZeneca facing 26,000 suits over Seroquel
Tags: product liability, Seroquel AstraZeneca is facing as many as 26,000 lawsuits over its antipsychotic drug Seroquel as the drug maker prepares for its first jury trial over claims the medicine causes diabetes, according to court filings.
|
|
|
AstraZeneca PLC (AZN) Facing 26,000 Lawsuits Over Seroquel
Bloomberg -- AstraZeneca Plc is facing as many as 26,000 lawsuits over its antipsychotic drug Seroquel as the drugmaker prepares for its first jury trial over c AstraZeneca PLC (AZN) Facing 26,000 Lawsuits Over Seroquel.
|
|
|
AstraZeneca facing 26,000 suits over Seroquel
AstraZeneca is facing as many as 26,000 lawsuits over its antipsychotic drug Seroquel as the drug maker prepares for its first jury trial over claims the medicine causes diabetes, according to court filings.AstraZeneca facing 26,000 suits over ...
|
|
|
AstraZeneca Facing 26,000 Lawsuits Over Seroquel (Update2)
3 (Bloomberg) -- AstraZeneca Plc is facing as many as 26,000 lawsuits over its antipsychotic drug Seroquel as the drugmaker prepares for its first jury trial over claims the medicine causes diabetes, according to court filings.Attorneys for AstraZeneca...
|
|
|
Big Pharma's Key Lifecycle Management Strategies
Bharatbook added a new report on 'Big Pharmas Key Lifecycle Management Strategies - Maximizing the Market Potential' which gives the strategy of LCM market in pharma industry Published on February 03, 2010by Sandhya Nair(OfficialWire)MUMBAI, INDIA Big Pharmas...
|
|
|
Big Pharma's Key Lifecycle Management Strategies
Bharatbook added a new report on "Big Pharmas Key Lifecycle Management Strategies - Maximizing the Market Potential" which gives the strategy of LCM market in pharma industry (OfficialWire) MUMBAI, INDIA Big Pharmas Key Lifecycle Management Strategies -...
|
|
|
Big Pharma's Key Lifecycle Management Strategies
Bharatbook added a new report on 'Big Pharmas Key Lifecycle Management Strategies - Maximizing the Market Potential' which gives the LCM strategy, expansion and popularity in the Pharmaceutical Industry.Big Pharmas Key Lifecycle Management Strategies -...
|
|
|
Major Drugmakers Post Higher Sales But a Mix on Profits
LINDA A.JOHNSON AP Business Writer TRENTON, N.J. (AP) ' Fourth-quarter revenues climbed about 10 percent for major drugmakers AstraZeneca PLC, Bristol-Myers Squibb Co. and Eli Lilly & Co., mainly buoyed by sales of drugs for heart disease, depression...
|
|
|
UK journal ad spins weight gain side effect
UK regulators vowed to investigate a medical journal ad for AstraZeneca's Seroquel that allegedly minimized weight gain data, a common side effect associated with atypical anti-psychotic drugs.The ad ran in the British Journal of Psychiatry in 2004, and...
|
|
|
Research and Markets: Who's Afraid of the Patent Cliff?
Research and Markets ( www.researchandmarkets.com/research/461bf1/whos_afraid_of_th : ) has announced the addition of the 'Who's Afraid of the Patent Cliff?' report to their offering.Nobody needs a crystal ball to predict the turn of the next decade as a...
|
|
|
AstraZeneca under legal spotlight and more news
It's been a bad week for drugs manufacturer AstraZeneca, which was the theme of a BBC Radio 4 investigative programme, and things could be about to get worse.AstraZeneca could face new legal action in the coming months over its anti-psychotic drug ...
|
|
|
Report: AstraZeneca facing costs of $1.2 billion over Seroquel lawsuits
AstraZeneca may have to pay as much as $1.2 billion in costs related to US lawsuits filed against the company over Seroquel (quetiapine), including more than $500 million as part of a deal to settle an investigation into the company's marketing of the...
|
|
|
AstraZeneca under legal spotlight and more news
It's been a bad week for drugs manufacturer AstraZeneca, which was the theme of a BBC Radio 4 investigative programme, and things could be about to get worse.AstraZeneca could face new legal action in the coming months over its anti-psychotic drug ...
|
|
|
Drugmakers post higher sales but a mix on profits
By LINDA A.JOHNSON AP Business Writer TRENTON, N.J. (AP) - Fourth-quarter revenues climbed about 10 percent for major drugmakers AstraZeneca PLC, Bristol-Myers Squibb Co. and Eli Lilly&Co., mainly buoyed by sales of drugs for heart disease,...
|
|
|
Drugmakers post higher sales but a mix on profits
By LINDA A.JOHNSON AP Business Writer TRENTON, N.J. (AP) - Fourth-quarter revenues climbed about 10 percent for major drugmakers AstraZeneca PLC, Bristol-Myers Squibb Co. and Eli Lilly&Co., mainly buoyed by sales of drugs for heart disease,...
|
|
|
AstraZeneca Layoffs: Blame the Lawyers (and the Seroquel Marketers)
AstraZeneca s: Blame the Lawyers (and the Seroquel Marketers) Blog DW.pageParams DW.regSilo Pine Sol's advertising is racist, according to Pepper Miller of the Hunter-Miller Group, an African American market research consultancy.The accusation is proof...
|
|
|
Drugmakers post higher sales but a mix on profits
TRENTON, N.J.(AP) - Fourth-quarter revenues climbed about 10 percent for major drugmakers AstraZeneca PLC, Bristol-Myers Squibb Co. and Eli Lilly&Co., mainly buoyed by sales of drugs for heart disease, depression and other mental illnesses. But...
|
|
|
Seroquel XR and Seroquel approved in Ireland
Seroquel XR (quetiapine fumarate extended-release tablets) and Seroquel (quetiapine fumarate) have been approved in Ireland for the prevention of recurrence of bipolar disorder in patients whose manic, mixed or depressive episode has responded to...
|
|
|
/C O R R E C T I O N Decision Resources/
In the news release, Seroquel and Seroquel XR Will Garner Nearly One Quarter of Antipsychotics Sales for Major Depressive Disorder By 2013, Following Seroquel XR's Approval as an Adjunctive Therapy for the Indication issued on January 27 by...
|
|
|
AZ faces $1.2B in Seroquel legal costs
Seroquel legal costs could take a $1.2 billion bite out of AstraZeneca's bottom line, the Financial Times reports.With a growing number of lawsuits from Seroquel patients and government regulators, the drugmaker may end up forking over that much...
|
|
|
Study: 'Corrupt' drug firm practices exposed
A FLINDERS University study has exposed 'corrupt' drug company marketing practices including covering up adverse side effects and pushing patients on to new, more expensive drugs even when they are less effective.Psychiatrist Peter Parry and American...
|
|
|
AstraZeneca Keeps Upper Hand in Seroquel War, But Cost of Each Case Is Rising
AstraZeneca (AZN) continues to have the upper hand in the Seroquel war -- it has now dismissed 26 percent of the pending cases against it, a larger portion than any of the previous nine months.AstraZeneca Keeps Upper Hand in Seroquel War, But...
|
|
|
Sales climb 10% for drugmakers
TRENTON, N.J.Fourth-quarter revenues climbed about 10 percent for major drugmakers AstraZeneca PLC, Bristol-Myers Squibb Co. and Eli Lilly & Co., mainly buoyed by sales of drugs for heart disease, and depression and other mental illnesses. But one...
|
